Join to view full profile
1630 SE 18th StSte 602Ocala, FL 34471
Phone+1 352-369-0181
Fax+1 352-369-0246
Dr. Acevedo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2001 - 2004- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 1998 - 2001
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1998
Certifications & Licensure
FL State Medical License 2004 - 2028
NJ State Medical License 2001 - 2005
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification OncoEMR by Flatiron Health, Flatiron Health, Inc., 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2014
Clinical Trials
- A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma Start of enrollment: 2013 Feb 01
Publications & Presentations
PubMed
- 13 citationsResults of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.John W. Smith, Kristi McIntyre, Patrick V. Acevedo, Carlos A. Encarnacion, Karen L. Tedesco
Breast Cancer Research and Treatment. 2009-05-21
Press Mentions
Cancer Survivors Find Support, Strength, HopeJune 3rd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
